by Mark Curtis | Jun 22, 2015
. Welcome to your deal review for the month of May. Juno Therapeutics was active, forming a strategic research collaboration with Fate Therapeutics and acquiring Stage Cell Therapeutics. Adaptimmune decided it would take advantage of the ongoing initial public...
by Stacey Johnson | Jun 19, 2015
.Today is a big day for the regenerative medicine (RM) community in Ontario, Canada. Minister of Research and Innovation, Reza Moridi, just announced that the Ontario Institute for Regenerative Medicine (OIRM) will receive a new $25 million commitment* (in addition to...
by David Kent | Jun 16, 2015
. Last week the German Stem Cell Network (SCN) released three videos on the current and future possibilities of stem cells. The videos feature three top tier scientists in the field – Andreas Trumpp, Magdalena Gotz and Anthony Ho – and treat viewers to their...
by Stacey Johnson | Jun 12, 2015
. Anthony Atala MD, of Wake Forest University, is a pioneer in the field of regenerative medicine and recognized for his trailblazing and visionary work in tissue engineering and building printable organs. Signals has somehow missed out on featuring his work, despite...
by Hamideh Emrani | Jun 8, 2015
. Some of my fond memories of childhood are from the times that my great grandma and grandpa visited us. They told us sweet stories and shared memories of much simpler times. But they had worries too. I vividly remember that one of my great grandmother’s main fears...
by Stacey Johnson | Jun 5, 2015
. Crystal Ruff is a Canadian regenerative neuroscience researcher who appears to have a fondness for stem cells, communicating science and London, England (not necessarily in that order). She studied at the undergraduate level at McMaster University in Hamilton,...
by Lisa Willemse | Jun 2, 2015
. A clinical trial set to begin this month in Ottawa will test the safety and efficacy of mesenchymal stem cells to stimulate repair of damaged nerves in MS patients. This article was published simultaneously on the Ontario Institute for Regenerative Medicine website....
by Mark Curtis | May 27, 2015
. Welcome to your deal review for the month of April. There is no update yet on the fate of the Cellular Dynamics International/Fujifilm deal, but it appears that CDI made some effort to solicit offers from alternative bidders. Aduro made headlines, though, closing a...
by Mark Curtis | May 25, 2015
. Welcome to your Update from the Clinic for the month of April. Mesenchymal stem cells took a hit as Athersys’ MultiStem came up short, missing its primary endpoint in a Phase 2 study investigating the cells for ischemic stroke. Juno Therapeutics continues to turn...
Comments